Geode Capital Management »

Xilio Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Xilio Therapeutics shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Xilio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Xilio Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xilio Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $313k 37k 8.41

More positions owned by Geode Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Meta Platforms Inc-class A Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Visa Inc-class A Shares Com Cl A (V)

View all positions for Geode Capital Management

Top funds holding Xilio Therapeutics

Bain Capital Life Sciences Investors
Frazier Life Sciences Management
Vanguard Capital Management
Merck & Co
Morgan Stanley
AJU IB Investment
Geode Capital Management
Vanguard Fiduciary Trust
GSA Capital Partners
Ghisallo Capital Management
UBS Group
Vanguard Global Advisers
Royal Bank of Canada
Key FInancial

View all funds holding Xilio Therapeutics